Currently Open Funding Opportunity Announcements Relevant to Healthcare Delivery Research

This page includes currently open Funding Opportunity Announcements (FOAs) sponsored or co-sponsored by HDRP; other FOAs relevant to HDRP; and NIH and NCI Parent and Omnibus FOAs for investigator-initiated research. Descriptions of the most commonly used grant mechanisms can be found on the NIH Grants & Funding pagesExternal Web Site Policy and full FOA presentations are available on the FOA webinars page. If you have questions about a grant application, please contact the NCI Program Director listed on the FOA.

FOAs Sponsored or Co-Sponsored by HDRP

Announcement Title Announcement Number
(Mechanism)
Expiration Date Program Contact
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-492External Web Site Policy (R21 Clinical Trial Optional)
PA-18-493External Web Site Policy (R01 Clinical Trial Optional)
May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Notice of Special Interest: Administrative Supplement for Modifiable Factors Potentially Affecting the Cost of Cancer Treatment NOT-CA-21-055External Web Site Policy June 19, 2021 Michael Halpern
240-276-5818
michael.halpern@nih.gov
Request for Information (RFI): Seeking Stakeholder Input on Enhancing Cancer Health Disparities Research NOT-CA-21-066External Web Site Policy
June 25, 2021 Brenda Adjei
240-276-6185
brenda.adjei@nih.gov
Investigator-Initiated Research on Genetic Counseling Processes and Practices RFA-HG-20-048External Web Site Policy (R01 Clinical Trial Optional) July 8, 2021 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity and Inclusion in the Cancer Research Workforce NOT-CA-21-067External Web Site Policy
July 15, 2021 Brenda Adjei
240-276-6185
brenda.adjei@nih.gov
Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required) RFA-CA-21-029External Web Site Policy July 21, 2021 Roxanne Jensen
240-276-7588
roxanne.jensen@nih.gov
Notice of Special Interest: Research to Improve the Interpretation of Patient-Reported Outcomes at the Individual Patient Level for Use in Clinical Practice NOT-OD-20-079External Web Site Policy January 8, 2022 Ashley Wilder-Smith
240-276-6714
smithas@mail.nih.gov
Notice of Special Interest: NCI’s Interest in Research to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-19-059External Web Site Policy January 8, 2022 Sallie Weaver
240-276-6254
sallie.weaver@nih.gov
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations PA-18-932External Web Site Policy (R01 Clinical Trial Optional) January 8, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-136External Web Site Policy (R01 Clinical Trial Optional)
PAR-19-153External Web Site Policy (R21 Clinical Trial Optional)
January 8, 2022 Ashley Wilder Smith
240-276-7621
smithas@mail.nih.gov
Notice of Special Interest: De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum NOT-CA-20-021External Web Site Policy May 10, 2022 Erica S. Breslau
240-276-6773
breslaue@mail.nih.gov
Surgical Disparities Research (R01) PAR-20-079External Web Site Policy July 6, 2022 Brenda Adjei
240-276-6185
brenda.adjei@nih.gov
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-359External Web Site Policy (R03 Clinical Trial Optional) July 17, 2022 Veronica Chollette
cholletv@mail.nih.gov
Notice of Special Interest: Health Services Research on Minority Health and Health Disparities NOT-MD-20-011External Web Site Policy (R01 Clinical Trial Optional) September 8, 2022 Brenda Adjei
240-276-6185 adjeiba@mail.nih.gov
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-360External Web Site Policy (R01 Clinical Trial Optional) September 8, 2022 Veronica Chollette
cholletv@mail.nih.gov
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-358External Web Site Policy (R21 Clinical Trial Optional) September 8, 2022 Veronica Chollette
cholletv@mail.nih.gov
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-352External Web Site Policy (R01 Clinical Trial Optional) September 8, 2022 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-355External Web Site Policy (R21 Clinical Trial Optional) September 8, 2022 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Notice of Special Interest: Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways NOT-CA-21-019External Web Site Policy
February 5, 2023 Michelle Mollica
240-276-7621
michelle.mollica@nih.gov
Notice of Special Interest: Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery NOT-CA-20-026External Web Site Policy May 8, 2023 Kate Castro
240-276-6834
kathleen.castro@nih.gov
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) PAR-20-179External Web Site Policy September 8, 2023 Bryan Kim
bryan.kim@nih.gov
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) PAR-20-180External Web Site Policy September 8, 2023 Bryan Kim
bryan.kim@nih.gov
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) PA-20-172External Web Site Policy September 8, 2023 Sallie Weaver
240-276-6254
sallie.weaver@nih.gov
Notice of Special Interest (NOSI): Telehealth in Cancer Care NOT-CA-21-043External Web Site Policy March 8, 2024 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Notice of Special Interest: Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health NOT-OD-21-100External Web Site Policy June 8, 2024 Janet de Moor
240-276-6806
janet.demoor@nih.gov
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) NOT-MD-21-016External Web Site Policy TBA Brenda Adjei
240-276-6185
brenda.adjei@nih.gov

Other FOAs Relevant to HDRP

Announcement Title Announcement Number
(Mechanism)
Expiration Date Program Contact
Dissemination and Implementation Research in Health PAR-19-274 (R01)External Web Site Policy
PAR-19-275 (R21)External Web Site Policy
PAR-19-276 (R03)External Web Site Policy
May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Wynne E. Norton, Ph.D.
National Cancer Institute (NCI)
240-276-6875
Wynne.Norton@nih.gov

David Chambers
240-276-5090
dchamber@mail.nih.gov

NIH and NCI Parent and Omnibus FOAs for Investigator-Initiated Research

Announcement Title Announcement Number
(Mechanism)
Expiration Date
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PAR-18-869External Web Site Policy March 9, 2021
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-20-185External Web Site Policy May 8, 2023
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-21-035External Web Site Policy January 8, 2024

Visit https://grants.nih.gov/grants/guide/parent_announcements.htmExternal Web Site Policy for a full list of all NIH parent announcements.

Last Updated: 17 May, 2021